FilingSEC EDGAR8-K
Annovis Bio Announces Preliminary Cash Position as of Sept 30, 2026
· SEC accepted
StageFinancial Disclosure
Filing content
Annovis Bio announced that its preliminary cash and cash equivalents were approximately $2.8 million as of September 30, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…